Romiplostim
CAS 267639-76-9Biologic
Overview
Romiplostim is a thrombopoietin receptor agonist used to increase platelet counts in patients with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It functions as a fusion protein linking a thrombopoietin receptor-binding domain to an Fc segment of human immunoglobulin.
Therapeutic areas
Hematology
Verified Supplier Partner
Do you supply Romiplostim? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.